Clinical decision support (CDS) aimed at reducing overuse of care in seniors does not yield durable changes in terms of prostate-specific antigen (PSA) screening in older men, but is durable for reducing urinary overtesting, according to a research letter published online Feb. 11 in the Annals of Internal Medicine.